COSMA
Research COSMA (COS.WA) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerCOS.WA
- ExchangeXNCO
- CountryPoland
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyPLN
- Financial periodQ2 2026
- RevenuePLN 7.28M
- Net incomePLN 1.91M
- Free cash flowPLN 276.34K
- Gross margin67.7%
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-11 | n/a | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 PLN.
About COSMA
Cosma S.A. engages in the manufacture and selling dietary supplements, cosmetics, and pharmaceutical raw materials based on natural ingredients, including hemp in Poland. The company's portfolio includes proprietary brands such as Cosma, Full Spectrum, and Green Paw, offering cannabinoid dietary supplements, cannabinoid cosmetics, hemp food products, feed additives, and plant extracts for both human and pet markets.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What does COSMA do?
Cosma S.A. engages in the manufacture and selling dietary supplements, cosmetics, and pharmaceutical raw materials based on natural ingredients, including hemp in Poland. The company's portfolio includes proprietary brands such as Cosma, Full Spectrum, and Green Paw, offering cannabinoid dietary supplements, cannabinoid cosmetics, hemp food products, feed additives, and plant extracts for both human and pet markets. It also engages in the import and distribution of pharmaceutical raw materials for the preparation of prescription drugs. The company was formerly known as Cosma Group S.A.